Skip Navigation


NDT Advance Access originally published online on April 5, 2008
Nephrology Dialysis Transplantation 2008 23(8):2571-2575; doi:10.1093/ndt/gfn069
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/8/2571    most recent
gfn069v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Innes, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Innes, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



The detection of advanced chronic kidney disease by surveillance of elevated plasma creatinines—a five-year experience

Andrew Innes

Department of Renal Medicine, Crosshouse Hospital, Kilmarnock, UK

Correspondence and offprint requests to: Andrew Innes, Department of Renal Medicine, Crosshouse Hospital, Kilmarnock, UK. Tel: +44-1563577358; Fax: +44-1563577987; Email: ainnes{at}aaaht.scot.nhs.uk



  Abstract

Background. The late referral of patients with advanced chronic renal failure to a nephrologist is multifactorial but also compromises the preparations for dialysis and is prejudicial to their survival on dialysis. Measures that prompt or hasten referral, will allow preparation for dialysis, control of complications and treatment of comorbid conditions.

Methods. In June 2000, a programme was initiated to provide surveillance of plasma creatinines >300 µmol/L on all laboratory requests from general practitioners (GPs) and hospital clinicians in Ayrshire and Arran Health Board in southwest Scotland. Patients already known to the nephrologists were excluded. Results were regularly reviewed and further excluded if the creatinine fell or the patient died. For the remainder, a standard letter was sent to the requesting clinician suggesting renal referral if appropriate. This was to act as a prompt to the general practitioner or hospital clinician. For those referred over the 5-year period, the outcome was analysed in January 2007.

Results. In the first 5 years (June 2000–June 2005) letters were sent regarding 246 patients (median age 76). Fifty-three patients still had reversible ARF or died within 3 months of the letter; seven were already referred. The requesting clinician felt that referral was not appropriate in 56; 23 were being reviewed elsewhere. The programme has led to the referral of 50 patients to the renal service (and 3 to others) but in 54 cases no reply was received and the letter ignored. Of the 50 referred, 17 entered the dialysis programme, 13 of whom had definitive dialysis access (fistula or Tenckhoff catheter) at the start. After a period of outpatient review they have undergone a median of 21 months of dialysis.

Conclusions. Over the 5-year period this programme has detected a cohort of patients who, in general, benefited from nephrological follow-up and dialysis. It may also act as a prompt to clinicians to refer more ‘marginal’ patients and thereby hasten future referral.

Keywords: five; nephrology; programme; surveillance; years

Received for publication: 10. 8.07
Accepted in revised form: 28. 1.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.